Predictive Health for the Modern Clinic
The genomic engine designed for scale, patient understanding, and clinical action.
23andMe Research Institute integrates seamlessly into your workflow to close the screening gap across diverse populations with clinical-grade insights and no specialized genetics expertise required.
Contact UsBacked by 13M+ customers and a dataset of 4B+ phenotypic data points.
Comprehensive Genomic Risk Assessment
Seamlessly integrate highly actionable exome findings with 50+ multi-ancestry polygenic risk scores and clinical risk models to deliver the most comprehensive view of patient risk available today.
Built for Long-term Patient Engagement
While other labs deliver static PDFs, we deliver a longitudinal, patient-friendly health experience that results in medical action.
Validated Science
Medical research institute delivering clinical insights backed by the world's largest genetic research cohort, with over 300 peer-reviewed publications in the world's leading medical journals.
1 in 11
Patients received a medically actionable, hereditary disease sequencing result, directly changing their care plan.1
82%
Of patients with highly actionable risks had no prior awareness before testing.2
88%
Of medical recommendations given to address genetic results were adhered to by patients.2
Why 23andMe Research Institute
Comprehensive Genomics Solution
Our clinical-grade exome sequencing screens 100+ genes for 55+ common, chronic diseases and high-impact conditions, including all those considered medically actionable by the American College of Medical Genetics and Genomics (ACMG).
Designed for Patient Comprehension
We've spent 20 years fine-tuning the delivery of genetic insights. Through our process of meeting FDA requirements for user comprehension and years of communicating about genetics to our members and the general public, we take care of effectively communicating complex and sometimes sensitive information, saving you valuable consult time. Patients arrive engaged and informed, allowing you to focus on the action plan.
Billion-Scale Insights at Point-of-Care
Our models are trained on a dataset of unprecedented scale, allowing for the identification of complex genetic patterns and "long-range" interactions that smaller clinical cohorts miss.
Protecting Your Patients' Privacy
We understand the responsibility of handling ePHI. Our platform complies with the HIPAA Security Rule and HIPAA's protection standards, utilizing administrative, physical, and technical safeguards to protect data integrity and patient privacy.
Connect with Us
Learn how 23andMe Research Institute can transform your clinical practice.